EZR and melanoma: Furthermore, the treatment of ERMs with cytochalasin B was shown to remarkably suppress the metastasis and phagocytic activity of melanoma cells, indicating that the inhibition of actin assembly by ezrin inhibitors may be a potential therapeutic tool for melanoma [281].